Adma Biologics ADMA
NASDAQ ADMA
$9.92 -0.04 (-0.40%)
As of: Sep 30, 2026 · 10:25 AM EDT

Adma Biologics (ADMA) Capital Expenditures (2011 - 2026)

Updated

Adma Biologics (ADMA) posted Capital Expenditures of $2.26 million for Q2 2026, down 6.9% from $2.42 million a year earlier and down 11.3% from the prior quarter.

Analysis

Adma Biologics (ADMA) Capital Expenditures (2011 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, Capital Expenditures at Adma Biologics was $20.25 million, up 85.2% year-over-year; for FY2025, it came in at $22.58 million, up 174.4% from FY2024.

  • Annual Capital Expenditures shows a five-year compound annual growth rate of 12.1% (FY2020 to FY2025).
  • In prior years, Adma Biologics' Capital Expenditures was $8.23 million in FY2024 (+72.4%), $4.77 million in FY2023 (-65.7%), $13.91 million in FY2022 (+3.0%) and $13.51 million in FY2021 (+6.2%).
  • Quarterly Capital Expenditures has run from a low of $757,000 in Q3 2023 to a high of $14.37 million in Q3 2025 over five years.
  • On a year-over-year basis, Capital Expenditures has declined in each of the last three quarters, with growth averaging 24.8% over the last seven quarters.
  • The strongest year-over-year quarter for Capital Expenditures in the past five years was Q2 2024, with growth of 136.9%; the weakest was Q2 2023, with a decline of 77.9%.
  • According to Business Quant data, Capital Expenditures for the three prior quarters was $2.54 million (Q1 2026), $1.08 million (Q4 2025) and $14.37 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 1.32 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 322.00 Mn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -763.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 140.00 Mn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 112.20 Mn
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn 2.26 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.26 Mn
Mar 31, 2026 2.54 Mn
Dec 31, 2025 1.08 Mn
Sep 30, 2025 14.37 Mn
Jun 30, 2025 2.42 Mn
Mar 31, 2025 4.70 Mn
Dec 31, 2024 2.76 Mn
Sep 30, 2024 1.06 Mn
Jun 30, 2024 2.07 Mn
Mar 31, 2024 2.35 Mn
Dec 31, 2023 1.20 Mn
Sep 30, 2023 757,000.00
Jun 30, 2023 872,000.00
Mar 31, 2023 1.95 Mn
Dec 31, 2022 3.75 Mn
Sep 30, 2022 3.38 Mn
Jun 30, 2022 3.94 Mn
Mar 31, 2022 2.84 Mn
Dec 31, 2021 3.68 Mn
Sep 30, 2021 2.79 Mn
API Access

Adma Biologics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ADMA&period=max&api_key=YOUR_API_KEY